Oddo maintains its 'outperform' rating on Carbios shares, with an unchanged target price of 45 euros.

The research firm points out that Carbios announced this morning the finalization of a long-term partnership with Novozymes for the supply of enzymes on an industrial scale.

Novozymes will produce and distribute enzymes to Carbios licensees. This important step forward for the Group will enable the scalability of Carbios' asset-light model", says Oddo.

The analyst considers that this announcement is "very good news" and that it "confirms the interest of the Carbios solution in the world of plastics recycling".

In this context, "the group should give slightly more precise guidance when it presents its annual results at the beginning of April", suggests the broker.

Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.